Riskpilot← Back to searchSign inGet full accessSkövdekliniken AB
ABActiveOrg 5590147632Hertig Johans Torg 2Beauty care and other beauty treatment activities · NACE 9622Est. 20158 employees
Revenue 2024
SEK 7,6M
-16% vs 2023
EBITDA margin
-2.5%
-122% vs 2023
Equity ratio
23.5%
Financial strength
Net profit 2024
SEK 275K
-58% vs 2023
| Revenue | SEK 7,6M | -16% |
| EBITDA | SEK -194K | -122% |
| Net profit | SEK 275K | -58% |
| Total assets | SEK 2,3M | -27% |
| Equity | SEK 545K | -37% |
| Employees | 8 | — |
Legal name
Skövdekliniken AB
Org number
5590147632
Legal form
Aktiebolag
NACE code
9622 · Beauty care and other beauty treatment activities
Founded
25 maj 2015
Share capital
SEK 50 000
Employees
8 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är skönhetsbehandlingar och därmed förenlig verksamhet.
Address
Hertig Johans Torg 2
Email
info@skovdekliniken.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 6 819 | 8 384 | 8 385 | 9 094 | 7 612 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 1 134 | 1 684 | 789 | 896 | −194 |
| Depreciation & amort. | −111 | −81 | −73 | −83 | −45 |
| EBIT | 1 023 | 1 603 | 716 | 813 | −239 |
| Net financials | −1 | −4 | −3 | −2 | −1 |
| Profit before tax | 1 035 | 1 408 | 563 | 840 | 359 |
| Tax | −224 | −294 | −116 | −178 | −84 |
| Net profit | 811 | 1 114 | 447 | 662 | 275 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 380 | 3 319 | 2 614 | 3 160 | 2 317 |
| Equity | 947 | 1 261 | 608 | 870 | 545 |
| Long-term debt | 30 | 0 | 0 | 0 | 0 |
| Short-term debt | 982 | 1 446 | 1 379 | 1 691 | 1 772 |
| Total debt | 1 012 | 1 446 | 1 379 | 1 691 | 1 772 |
EBITDA margin
-2.5%
This company
15.8%
Market median
-116% vs market
20202024
Equity ratio
23.5%
This company
38.2%
Market median
-38% vs market
20202024
Return on equity
50.5%
This company
18.4%
Market median
+174% vs market
20202024
Net profit margin
3.6%
This company
8.1%
Market median
-56% vs market
20202024
Asset turnover
3.29×
This company
1.12×
Market median
+194% vs market
20202024
Debt / equity
3.25×
This company
0.62×
Market median
-424% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
CA | Audit | 2025 |
| Former (1) | ||
BH | Audit | 2020 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2021 | |
| Board of Directors | 2020 | |
| Former (1) | ||
| Deputy Board Member | 2020 – 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Skövdekliniken AB 
Skövdekliniken i Stockholm ABBoard members of Skövdekliniken AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Christer Allan Jansson | Audit | 0 companies |
| Bengt Hans Peter Karlsson | Audit | 0 companies |
| Martin Khamo | Deputy Board Member | 0 companies |
| Juliet B Solaka | Deputy Board Member | 0 companies |
| Caroline Shamiram Solaka | Board of Directors | 0 companies |